Unknown NA INTERVENTIONAL 2-arm NCT04030819

Effectiveness of a Schema Therapy on Anxiety in Patients With Multiple Sclerosis

Effectiveness of a Schema Therapy on Anxiety in Patients With Multiple Sclerosis .a Randomized Control Study in 106Persian Patients With Relapsing Remitting Multiple Sclerosis (RRMS)

Sponsor: Isfahan University of Medical Sciences

Conditions Anxiety

Interventions schema therapy

Updated 5 times since 2019 Last updated: Jul 27, 2019 Started: Dec 20, 2018 Primary completion: Jun 18, 2019 Completion: Dec 15, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Anxiety, this trial is ongoing. The trial is conducted by Isfahan University of Medical Sciences and has accumulated 5 data snapshots since 2018. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Oct 2021 — Jul 2024 [monthly]

Unknown Status NA

Status: Active Not Recruiting → Unknown Status
Jan 2021 — Oct 2021 [monthly]

Active Not Recruiting NA
Aug 2019 — Jan 2021 [monthly]

Active Not Recruiting NA

First recorded

Dec 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Isfahan University of Medical Sciences
Paris Nanterre University

Data source: Paris Nanterre University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Paris, France